Clinical Trial Update: Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence trial comparing generic imiquimod 5% cream to Aldara 5% in actinic keratosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Aldara Imiquimod Cream 5% (Imiquimod)
• Imiquimod 5% cream (generic) (Imiquimod)

Snippet

Sponsor: Actavis Inc. | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED | Results posted: 2020-09-04